Hi Misiu. I am not suggesting that we need to k
Post# of 148304
I am not suggesting that we need to know the details of what was not signed, but something more like "Given what we knew about the potential of Leronlimab months ago when these negotiations started, and then what we subsequently learned (for cancer, as an example), the offer that we had was no longer viable as the value of Leronlimab is now potentially exponentially higher than first known."
Things often shift during negotiations, and, for example, if you were in negotiations to buy a piece of property for $100,000 but then the seller learned the property had oil under it, you may not have enough to offer the seller for what the new information brings as to the value of the property, even though $100,000 was initially a fair price. Hopefully that is what happened here with Leronlimab.